Literature DB >> 10600929

Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter.

M Demeule1, M Brossard, R Béliveau.   

Abstract

The expression of two members of the ATP-binding cassette family of transport proteins, P-glycoprotein (P-gp) and the canalicular multispecific organic anion transporter (cMOAT or Mrp2), was evaluated in renal brush-border membranes (BBM) and various rat tissues after cisplatin treatment. One administration of cisplatin (5 mg/kg) increased P-gp expression by >200-300% in renal BBM and in crude membranes from liver and intestine. The increase in P-gp expression in the kidney was also detected in photolabeling experiments, suggesting the induction of functional P-gp. cMOAT expression was increased by >10-fold in renal BBM after cisplatin administration, although it had no effect on liver cMOAT expression. The increase in the levels of both proteins was maximal at 2 days after cisplatin treatment and lasted for at least 8 days. These results indicate that a single administration of cisplatin induces overexpression of P-gp and cMOAT in specific tissues. This may be of significant relevance to the design of clinical trials using cisplatin as a single chemotherapeutic agent or in combination with other drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600929     DOI: 10.1152/ajprenal.1999.277.6.F832

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy.

Authors:  Andreas-Claudius Hoffmann; Peter Wild; Christina Leicht; Simone Bertz; Kathleen D Danenberg; Peter V Danenberg; Robert Stöhr; Michael Stöckle; Jan Lehmann; Martin Schuler; Arndt Hartmann
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

Review 2.  Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.

Authors:  Tessa M Bosch; Irma Meijerman; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  P-glycoprotein induction and tumor cell-kill dynamics in response to differential doxorubicin dosing strategies: a theoretical pharmacodynamic model.

Authors:  Kenneth T Luu; James A Uchizono
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

Review 4.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

5.  Different modalities of intercellular membrane exchanges mediate cell-to-cell p-glycoprotein transfers in MCF-7 breast cancer cells.

Authors:  Jennifer Pasquier; Ludovic Galas; Céline Boulangé-Lecomte; Damien Rioult; Florence Bultelle; Pierre Magal; Glenn Webb; Frank Le Foll
Journal:  J Biol Chem       Date:  2012-01-06       Impact factor: 5.157

6.  Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.

Authors:  Helen H W Chen; Macus Tien Kuo
Journal:  Met Based Drugs       Date:  2010-09-14

7.  Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment.

Authors:  Lauren M Aleksunes; Lisa M Augustine; George L Scheffer; Nathan J Cherrington; José E Manautou
Journal:  Toxicology       Date:  2008-07-02       Impact factor: 4.221

8.  A mathematical feasibility argument for the use of aptamers in chemotherapy and imaging.

Authors:  Khalid Boushaba; Howard Levine; Marit Nilsen Hamilton
Journal:  Math Biosci       Date:  2009-06-18       Impact factor: 2.144

9.  Effect of cisplatin-induced acute renal failure on bioavailability and intestinal secretion of quinolone antibacterial drugs in rats.

Authors:  Hiroaki Yamaguchi; Ikuko Yano; Hideyuki Saito; Ken-ichi Inui
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

Review 10.  Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?

Authors:  Dirk Theile; Pauline Wizgall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.